128 related articles for article (PubMed ID: 30686809)
1. La-Related Protein 4 as a Suppressor for Motility of Ovarian Cancer Cells.
Egiz M; Usui T; Ishibashi M; Zhang X; Shigeta S; Toyoshima M; Kitatani K; Yaegashi N
Tohoku J Exp Med; 2019 Jan; 247(1):59-67. PubMed ID: 30686809
[TBL] [Abstract][Full Text] [Related]
2. The RNA-binding protein LARP4 regulates cancer cell migration and invasion.
Seetharaman S; Flemyng E; Shen J; Conte MR; Ridley AJ
Cytoskeleton (Hoboken); 2016 Nov; 73(11):680-690. PubMed ID: 27615744
[TBL] [Abstract][Full Text] [Related]
3. LARP1 and LARP4: up close with PABP for mRNA 3' poly(A) protection and stabilization.
Mattijssen S; Kozlov G; Fonseca BD; Gehring K; Maraia RJ
RNA Biol; 2021 Feb; 18(2):259-274. PubMed ID: 33522422
[TBL] [Abstract][Full Text] [Related]
4. Ceramide synthase 2-C
Zhang X; Sakamoto W; Canals D; Ishibashi M; Matsuda M; Nishida K; Toyoshima M; Shigeta S; Taniguchi M; Senkal CE; Okazaki T; Yaegashi N; Hannun YA; Nabe T; Kitatani K
FASEB J; 2021 Feb; 35(2):e21287. PubMed ID: 33423335
[TBL] [Abstract][Full Text] [Related]
5. The La-Related Proteins, a Family with Connections to Cancer.
Stavraka C; Blagden S
Biomolecules; 2015 Oct; 5(4):2701-22. PubMed ID: 26501340
[TBL] [Abstract][Full Text] [Related]
6.
Mattijssen S; Arimbasseri AG; Iben JR; Gaidamakov S; Lee J; Hafner M; Maraia RJ
Elife; 2017 Sep; 6():. PubMed ID: 28895529
[TBL] [Abstract][Full Text] [Related]
7. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer.
Zhang X; Su X; Guo Z; Jiang X; Li X
J Clin Lab Anal; 2020 Jul; 34(7):e23272. PubMed ID: 32187743
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of RhoA expression alters ovarian cancer biological behavior in vitro and in nude mice.
Wang X; Jiang W; Kang J; Liu Q; Nie M
Oncol Rep; 2015 Aug; 34(2):891-9. PubMed ID: 26035556
[TBL] [Abstract][Full Text] [Related]
10. LARP4 Is Regulated by Tumor Necrosis Factor Alpha in a Tristetraprolin-Dependent Manner.
Mattijssen S; Maraia RJ
Mol Cell Biol; 2016 Feb; 36(4):574-84. PubMed ID: 26644407
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA_LARP4 is lower expressed and serves as a potential biomarker of ovarian cancer prognosis.
Zou T; Wang PL; Gao Y; Liang WT
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7178-7182. PubMed ID: 30468459
[TBL] [Abstract][Full Text] [Related]
12. La-related protein 4 binds poly(A), interacts with the poly(A)-binding protein MLLE domain via a variant PAM2w motif, and can promote mRNA stability.
Yang R; Gaidamakov SA; Xie J; Lee J; Martino L; Kozlov G; Crawford AK; Russo AN; Conte MR; Gehring K; Maraia RJ
Mol Cell Biol; 2011 Feb; 31(3):542-56. PubMed ID: 21098120
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA_LARP4 inhibits cell migration and invasion of prostate cancer by targeting FOXO3A.
Weng XD; Yan T; Liu CL
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5303-5309. PubMed ID: 32495863
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA_LARP4 inhibits the progression of non-small-cell lung cancer by regulating the expression of SMAD7.
Shi JQ; Wang B; Cao XQ; Wang YX; Cheng X; Jia CL; Wen T; Luo BJ; Liu ZD
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1863-1869. PubMed ID: 32141555
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.
Horiuchi A; Kikuchi N; Osada R; Wang C; Hayashi A; Nikaido T; Konishi I
Cancer Sci; 2008 Dec; 99(12):2532-9. PubMed ID: 19038009
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression.
Zhang J; Liu H; Hou L; Wang G; Zhang R; Huang Y; Chen X; Zhu J
Mol Cancer; 2017 Sep; 16(1):151. PubMed ID: 28893265
[TBL] [Abstract][Full Text] [Related]
17. Effects of shRNA-mediated knockdown of SPOCK1 on ovarian cancer growth and metastasis.
Zhang LQ; Wang Y; Zhang L
Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):102-9. PubMed ID: 26638890
[TBL] [Abstract][Full Text] [Related]
18. Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer cells.
Chen D; Wang J; Zhang Y; Chen J; Yang C; Cao W; Zhang H; Liu Y; Dou J
Int J Gynecol Cancer; 2013 Oct; 23(8):1357-66. PubMed ID: 24257549
[TBL] [Abstract][Full Text] [Related]
19. High WAVE3 expression correlates with proliferation, migration and invasion in human ovarian cancer.
Lu J; Wang SL; Wang YC; Wu YN; Yu X; Zhao WZ; Wang JH
Oncotarget; 2017 Jun; 8(25):41189-41201. PubMed ID: 28476025
[TBL] [Abstract][Full Text] [Related]
20. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
